77,962 Shares in LENSAR, Inc. $LNSR Purchased by Man Group plc

Man Group plc purchased a new position in shares of LENSAR, Inc. (NASDAQ:LNSR) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 77,962 shares of the company’s stock, valued at approximately $445,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Brandes Investment Partners LP grew its stake in shares of LENSAR by 10.1% in the 4th quarter. Brandes Investment Partners LP now owns 856,216 shares of the company’s stock valued at $9,958,000 after purchasing an additional 78,513 shares during the period. Vanguard Group Inc. lifted its position in shares of LENSAR by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 507,603 shares of the company’s stock worth $6,269,000 after buying an additional 1,446 shares during the period. Geode Capital Management LLC lifted its position in shares of LENSAR by 103.9% during the 2nd quarter. Geode Capital Management LLC now owns 219,373 shares of the company’s stock worth $2,890,000 after buying an additional 111,802 shares during the period. Groupe la Francaise boosted its stake in LENSAR by 16.2% in the 1st quarter. Groupe la Francaise now owns 213,537 shares of the company’s stock valued at $1,273,000 after buying an additional 29,813 shares in the last quarter. Finally, BlackRock Inc. acquired a new stake in LENSAR in the 2nd quarter valued at $1,057,000. Institutional investors own 40.15% of the company’s stock.

Wall Street Analysts Forecast Growth

LNSR has been the subject of several recent analyst reports. Weiss Ratings lowered LENSAR from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday, August 21st. Lake Street Capital reaffirmed a “buy” rating and issued a $13.00 target price on shares of LENSAR in a report on Thursday, August 13th. BTIG Research increased their target price on shares of LENSAR from $9.00 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, August 20th. Finally, Wall Street Zen raised shares of LENSAR from a “hold” rating to a “buy” rating in a report on Sunday, August 23rd. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, LENSAR has an average rating of “Hold” and a consensus target price of $11.50.

LENSAR Price Performance

LNSR stock opened at $8.58 on Friday. The business has a fifty day moving average price of $6.70 and a 200 day moving average price of $6.97. LENSAR, Inc. has a fifty-two week low of $4.95 and a fifty-two week high of $12.94. The stock has a market capitalization of $105.45 million, a price-to-earnings ratio of -26.00 and a beta of 0.97.

LENSAR (NASDAQ:LNSR) last posted its quarterly earnings data on Thursday, August 13th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.26. The company had revenue of $16.50 million for the quarter, compared to analyst estimates of $14.65 million. LENSAR had a negative return on equity of 529.08% and a net margin of 57.57%.

LENSAR Profile

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.